Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erxuan Wang"'
Autor:
Zhendong Chen, Hong Qian, Nianfei Wang, Dayong Luo, Mu Yuan, Xinzhong Li, Qingsheng Kan, Erxuan Wang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/1ecdba47802449a99e3b76afc2335db2
Autor:
Xinzhong Li, Dayong Luo, Nianfei Wang, Qingsheng Kan, Zhendong Chen, Bo Jiang, Erxuan Wang, Hong Qian, Chunmei Yao, Mu Yuan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized the landscape of PLC management at all evolutionary stages.1 As an anti-programmed cell death-1 (PD-1) antibody, camrelizumab monotherapy and in combination with apatinib, an anti-angi